College of Food Science, Sichuan Agricultural University, Yaan 625014, China.
College of Food Science, Sichuan Agricultural University, Yaan 625014, China.
Int J Biol Macromol. 2018 Jul 15;114:632-639. doi: 10.1016/j.ijbiomac.2018.03.161. Epub 2018 Mar 27.
Selenium nanoparticles (SeNPs) were prepared by adding Catathelasma ventricosum polysaccharides (CVPs) to the redox system of selenite and ascorbic acid. Taking particle size as an investigation index, the optimal synthesis conditions of CVPs-SeNPs were obtained by orthogonal test. Herein, the diameter, morphology, and stability of the CVPs-SeNPs were characterized by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Moreover, the antidiabetic activities of CVPs-SeNPs were evaluated by STZ (streptozocin)-induced diabetic mice. The obtained results showed that, optimum synthesis conditions of CVPs-SeNPs were: ultrasonic time 60min, concentration of Vc 0.04M, reaction time 2h, pH7.0. Under these conditions, mean diameter of the synthesized CVPs-SeNPs was around 49.73nm. TEM of CVPs-SeNPs prepared in optimal conditions showed individual and spherical nanostructure. CVPs-SeNPs (particle size of about 50nm) could be stable for approximately 3months at 4°C, but only 1month at 25°C. The results on serum profiles and antioxidant enzymes levels revealed that CVPs-SeNPs had a potential antidiabetic effect. In addition, CVPs-SeNPs showed significantly higher antidiabetic activity (p<0.05) than other selenium preparations such as SeNPs, selenocysteine, sodium selenite.
采用添加 Catathelasma ventricosum 多糖(CVPs)到亚硒酸盐和抗坏血酸的氧化还原体系的方法制备硒纳米颗粒(SeNPs)。以粒径为考察指标,通过正交试验得到了 CVPs-SeNPs 的最佳合成条件。在此,通过动态光散射(DLS)和透射电子显微镜(TEM)对 CVPs-SeNPs 的粒径、形貌和稳定性进行了表征。此外,还通过链脲佐菌素(STZ)诱导的糖尿病小鼠评估了 CVPs-SeNPs 的抗糖尿病活性。结果表明,CVPs-SeNPs 的最佳合成条件为:超声时间 60min、Vc 浓度 0.04M、反应时间 2h、pH7.0。在这些条件下,合成的 CVPs-SeNPs 的平均粒径约为 49.73nm。在最佳条件下制备的 CVPs-SeNPs 的 TEM 显示出单个和球形的纳米结构。CVPs-SeNPs(粒径约为 50nm)在 4°C 下可稳定约 3 个月,但在 25°C 下仅可稳定 1 个月。血清谱和抗氧化酶水平的结果表明,CVPs-SeNPs 具有潜在的抗糖尿病作用。此外,CVPs-SeNPs 表现出比其他硒制剂(如 SeNPs、硒代半胱氨酸、亚硒酸钠)更高的抗糖尿病活性(p<0.05)。